Warner Music Group Corp. is well-positioned for higher-margin catalog revenues, added streaming adoption, and new AI monetization opportunities.
ARC Resources keeps returning its cash flow to shareholders through a growing dividend and substantial share buybacks.
These aren’t space startups: discover 7 dividend-paying aerospace and defense contractors tied to NASA’s Artemis mission (from TSI’s latest Globe and Mail column).
Become a Successful Investor
Learn the biggest investing for retirement mistakes Canadians over 45 make, plus safer ways to build steady income with stocks, ETFs, and REITs.
What are the most profitable stocks to buy? Blue chip stocks are included in that group—and here are the key characteristics you need to target for maximum success
Columbia Sportswear Co., $51.09, symbol COLM on Nasdaq (Shares outstanding: 70.3 million; Market cap: $3.4 billion; www.columbia.com), is a leading maker of outdoor apparel (80% of sales) and footwear (20%). The company’s main brands include Columbia, Sorel, Mountain Hardware, Montrail, OutDry and Pacific Trail. It sells most of its products through mass retailers. It also operates its own stores and sells goods online. The U.S. accounts for about 57% of its sales, followed by Latin America/Asia Pacific (24%), Europe (12%) and Canada (7%)....
GW Pharmaceuticals PLC (ADR), $55.37, symbol GWPH on Nasdaq (ADRs outstanding: 21.9 million; Market cap: $1.2 billion; www.gwpharm.com), is a U.K.-based firm that is developing pharmaceutical drugs derived from cannabis (marijuana). GW started up in 1998. It began trading on the London Stock Exchange in 2001. The company listed its ADRs on Nasdaq in May 2013 with an offering of 3.5 million ADRs at $8.90 each (one American Depositary Receipt is equal to 12 GW common shares). The company’s main product, Sativex, relieves symptoms in patients with multiple sclerosis. The drug comes as a peppermint-flavoured mouth spray. Sativex is now available in 28 countries—but not in the U.S....
Sell stocks in a way that consistently improves your portfolio without predicting when to “buy low and sell high.”
If you let share price fluctuations dictate your buying and selling, you’re almost certain to lose money.